Effect of Amnion Membrane With and Without Taurine on GCF TNF α Level.

NCT04772508 — Not applicable, Completed, 45 participants, Maharishi Markendeswar University (Deemed to be University)

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Efficacy of Subgingivally Placed Amnion Membrane With and Without Taurine as an Adjunct to Scaling and Root Planing in the Treatment of Chronic Periodontitis

RegistryNCT04772508
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: double, treatment
Enrollment45 (Actual)
SponsorMaharishi Markendeswar University (Deemed to be University) (Other)
ConditionsPeriodontitis
InterventionsScaling and root planing, Amnion membrane, Taurine (Procedure, biological, drug)
Datesstart 2020-12-01, primary completion 2021-03-13, completion 2021-03-13, first posted 2021-02-26, last updated 2021-03-16
Locations1 site in India

Related Papers Related Patents Related Grants Related Experts
All trials for Periodontitis All trials of Scaling and root planing All trials of Amnion membrane

-Summary

45 sites in 15 patients with periodontal pockets ≥ 5mm were selected. These selected sites were divided into 3 groups as Group A, B and C.

Expand all sections  ·  Collapse all

+Detailed description

Group A (Control): 15 sites received only SRP, Group B: 15 sites received SRP with subgingival placement of amnion membrane, Group C: 15 sites received SRP with subgingival placement of Amnion membrane hydrated with Taurine.

+Arms and interventions

ArmTypeInterventionsDescription
Group ASham comparatorProcedure: Scaling and root planing15 sites received only scaling and root planing
Group BActive comparatorProcedure: Scaling and root planing; Biological: Amnion membrane15 sites received scaling and root planing with subgingival placement of amnion membrane
Group CActive comparatorProcedure: Scaling and root planing; Biological: Amnion membrane; Drug: Taurine15 sites received scaling and root planing with subgingival placement of amnion membrane hydrated with Taurine
  • Scaling and root planing (Procedure), also known as SRP: 15 sites with periodontal pockets ≥ 5mm received only SRP
  • Amnion membrane (Biological), also known as AM: 15 sites with periodontal pockets ≥ 5mm received SRP along with placement of amnion membrane.
  • Taurine (Drug), also known as T: 15 sites with periodontal pockets ≥ 5mm received SRP along with placement of amnion membrane hydrated with taurine.

+Outcome measures

Primary outcomes

  • TNF-α level [changes from baseline to 45 days]: TNF-α level in Gingival crevicular fluid
  • Probing pocket depth (PPD) [changes from baseline to 45 days]: Probing pocket depth at selected site
  • Relative attachment level (RAL) [changes from baseline to 45 days]: Relative attachment level from stent to base of the pocket

Secondary outcomes

  • Plaque index (PI) [changes from baseline to 45 days]: Plaque index (PI) - Silness and Loe 1964 site specific
  • Gingival index (GI) [changes from baseline to 45 days]: Gingival index (GI) - Loe and Silness 1963 site specific
  • Bleeding on probing (BOP) [changes from baseline to 45 days]: Bleeding on probing (BOP): Muhlemann HR \& Son 1971 sit specific

+Eligibility

Sex: All, ages: 29 Years to 60 Years

Inclusion Criteria:

•Systemically healthy patients with sites showing probing depth (PD) ≥ 5mm, clinical attachment level (CAL) ≥ 4 mm, and vertical bone loss ≥ 3 mm on intraoral periapical radiographs with no history of periodontal therapy or use of antibiotics in the preceding 6 months

Exclusion Criteria:

* Any systemic disease that could influence the outcome of periodontal therapy.
* Smokers, alcoholics \& patients with other adverse habits.
* Pregnant or nursing women.
* Any known allergy or hypersensitivity to any product used in the study.
* Patients on long term systemic therapy (antibiotics, anti-inflammatory and any other).

+Locations (1)

FacilityCityCountryStatus
Department of Periodontology, M.M. College of Dental Sciences and Research.Ambāla, HaryanaIndia

+Publications

  • Giris M, Depboylu B, Dogru-Abbasoglu S, Erbil Y, Olgac V, Alis H, Aykac-Toker G, Uysal M. Effect of taurine on oxidative stress and apoptosis-related protein expression in trinitrobenzene sulphonic acid-induced colitis. Clin Exp Immunol. 2008 Apr;152(1):102-10. doi: 10.1111/j.1365-2249.2008.03599.x. Epub 2008 Jan 28. PMID 18241224
  • Gultekin SE, Senguven B, Sofuoglu A, Taner L, Koch M. Effect of the topical use of the antioxidant taurine on the two basement membrane proteins of regenerating oral gingival epithelium. J Periodontol. 2012 Jan;83(1):127-34. doi: 10.1902/jop.2011.100568. Epub 2011 May 16. PMID 21574832

+Investigators

  • surinder sachdeva, M.D.S., Study director, PROFESSOR